Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd. > RE:RE:RE:RE:RE:RE:News - Submits for IRB Approval w/ FDA
View:
Post by PowerofNow on Aug 26, 2020 10:39am

RE:RE:RE:RE:RE:RE:News - Submits for IRB Approval w/ FDA

What is an IRB? An institutional review board is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. According to the FDA’s website, ‘the purpose of IRB review is to assure, both in advance and by periodic review, that appropriate steps are taken to protect the rights and welfare of humans participating as subjects in the research. To accomplish this purpose, IRBs use a group process to review research protocols and related materials (e.g., informed consent documents and investigator brochures) to ensure protection of the rights and welfare of human subjects of research.’ Exploring FDA Expanded Access Program The company also announced that given the pandemic and urgency for new treatments, they will be exploring the FDA Expanded Access Program (aka Compassionate Use Program). The Expanded Access Programs provide patients with a path to receive an investigational drug for a serious disease or condition. These investigational drugs are often made available when there are no comparable or satisfactory alternative therapies to treat the disease or condition, where patient enrollment in clinical trials is not possible, the potential patient benefit justifies the potential risk of treatment and when providing the investigational drug will not interfere with clinical trials that could support the drug’s marketing approval for the treatment indication.
Comment by Covid19 on Aug 26, 2020 11:01am
Comment by Covid19 on Aug 26, 2020 11:03am
Comment by Covid19 on Aug 26, 2020 11:03am
Comment by PowerofNow on Aug 26, 2020 12:48pm
Comment by pinkfloyd90 on Aug 26, 2020 12:50pm
STOP PUMPING AND MISLEADING INVESTORS...the stock will move when we get bought out....how many oink oinks do I need to send to you...
Comment by PowerofNow on Aug 26, 2020 2:05pm
Comment by PowerofNow on Aug 26, 2020 12:51pm
Comment by PowerofNow on Aug 26, 2020 12:51pm
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities